StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Manas Jaiswal

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))27 Aug 2026via CNBC Awaaz.

Entry₹1,190Inferred
Target₹1,205
Total upside +1.26% (call closed)
Stop loss₹1,125-5.46% risk
Exit₹1,1254 Sept 2026, 3:05 pm
Stop-loss hit-5.46%
Follow Manas Jaiswal for new calls(30% target hit, 374 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 142 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Sept 2026
7 supporting0 opposing
Supports the BUY call (7)

Zydus Lifesciences announced positive topline results from the completed EVIDENCES-X Phase II(b) clinical trial of Saroglitazar Mg for MASH.

BSE · Company Update·31 Aug · 4d ago

(opens in new tab)

Zydus Lifesciences Share Price In Focus After Macquarie Maintains Outperform Rating. Here's Why

NewsNdtv-Profit·27 Aug · 1w ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·27 Aug · 1w ago

Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection

NewsNdtv-Profit·21 Aug · 2w ago

(opens in new tab)

Zydus Lifesciences gets USFDA approval for generic Ascorbic Acid Injection

NewsCnbc-Tv18·21 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Manas Jaiswal

Every call and its outcome